accreditation statistics

As of April 6, 2022

Cellular Therapy Entities

  • Accredited: 246
  • Applicants: 19

Cord Blood Banks

  • Accredited: 56
  • Applicants: 7

Congratulations to the following organizations for achieving their initial accreditations: South Texas Blood & Tissue Center (Collections at BioBridge Global Campus), San Antonio, Texas and University of California, Irvine (UCI), Orange, California.

A complete list of accredited organizations can be found at www.factwebsite.org.

Free SITC Webinars on Immune Effector Cell-Related Adverse Events Are Now On Demand

Posted in :: 2021 Volume 5 :: Tuesday, October 26th, 2021

SITC created a series of webinars on immune effector cell (IEC)-related adverse events to further educate clinical providers on how to respond to these events. The recordings are now available on demand and include:

  • SITC Clinical Practice Guideline Webinar – Immune Effector Cell-related Adverse Events (available on demand)
  • SITC Clinical Practice Guideline Webinar – Practical Management Pearls for Immune Effector Cell-related Adverse Events (available on demand)
  • SITC Clinical Practice Guideline Webinar – Case Studies in Immune Effector Cell-related Adverse Events: October 13, 2021, 5:30 PM – 6:30 PM ET (open for registration)

Visit the SITC website for more information.

In late 2020, SITC announced the publication of The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events in the Journal for ImmunoTherapy of Cancer (JITC). FACT was pleased to be a part of this effort, represented by Dr. Elizabeth Shpall, current member of FACT’s Immune Effector Cell Task Force and FACT’s first Board president when it was founded 25 years ago. The guideline addresses risk assessment, identification, and management for clinically significant side effects.